Navigation path

HOME
Policy areas
Sectors
Who is in charge?
Competition and you
Cases
In this section:
Overview
What's new?
Cases >
Documents
Sector inquiry

Pharmaceuticals

What's new?

17.07.2017 Antitrust: Commission sends Statement of Objections to Teva on 'pay for delay' pharma agreement 
15.05.2017 Antitrust: Commission opens formal investigation into Aspen Pharma's pricing practices for cancer medicines
23.11.2016 Mergers: Commission approves acquisition of St Jude Medical by Abbott Laboratories, subject to conditions
09.11.2016 Mergers: Commission approves acquisition of Sanofi's animal health business Merial by Boehringer Ingelheim, subject to conditions
02.12.2015 Sixth report on the monitoring of patent settlement agreements in the pharmaceutical sector
28.01.2015 Mergers: Commission approves acquisition of Abbott Laboratories' Non-U.S. Developed Markets Specialty and Branded Generics Business by Mylan, subject to conditions
28.01.2015 Mergers: Commission approves acquisition of GSK's oncology business by Novartis, subject to conditions
28.01.2015 Mergers: Commission approves both GSK's acquisition of Novartis' vaccines business and a consumer healthcare joint venture between GSK and Novartis, subject to conditions
22.12.2014 Mergers: Commission approves IMS Health's acquisition of parts of Cegedim, subject to conditions
05.12.2014 Fifth report on the monitoring of patent settlement agreements in the pharmaceutical sector
03.10.2014 Mergers: Commission approves acquisition of Novartis Animal Health division by Eli Lilly
10.12.2013 Antitrust: Commission fines Johnson & Johnson and Novartis € 16 million for delaying market entry of generic pain-killer fentanyl
09.12.2013 Antitrust: Commission welcomes continued low level of potentially problematic patent settlements in EU pharma sector
04.12.2013 State aid: Commission approves aid for innovative medical services in remote areas of Saxony
24.07.2013 State aid: Commission opens in-depth inquiry into alleged aid to German pharmaceutical companies in financial difficulties
19.06.2013 Antitrust: Commission fines Lundbeck and other pharma companies for delaying market entry of generic medicines
31.01.2013 Antitrust: Commission sends Statement of Objections to J&J and Novartis on delayed entry of generic pain-killer
06.12.2012 Antitrust: Commission welcomes Court of Justice judgment in the AstraZeneca case
12.11.2012 Mergers: Commission approves acquisition of Teva's over the counter business by Procter & Gamble
05.10.2012 Mergers: Commission approves acquisition of pharma company Actavis by rival Watson
08.08.2012 Mergers: Commission approves acquisition of medical device company BSN Medical by Guernsey based investment fund EQT VI
30.07.2012 Antitrust: Commission sends Statement of Objections on perindopril to Servier and others
25.07.2012 State aid: Commission enforcement action in pharmaceutical sector following sector inquiry
25.07.2012 Commission sends Statement of Objections to Lundbeck and others for preventing market entry of generic antidepressant medicine
08.05.2012 State aid: Commission launches major initiative to modernise state aid control
08.05.2012 State aid: the Commission clears 23 million EUR R&D aid to Novartis Italy for faster access to innovative vaccines in developing countries
19.04.2012 Mergers: Commission approves acquisition of medical device company Synthes by Johnson & Johnson
18.04.2012 Mergers: Commission approves acquisition of Air Products Homecare by Linde
30.03.2012 Competition policy for the post-crisis era
01.03.2012 Antitrust: Commission closes investigation in pharmaceutical companies AstraZeneca and Nycomed
10.02.2012 Mergers: Commission approves acquisition of Teeuwissen, Quintet, Jagero II and Bioiberica by Saria in the food and pharmaceutical sectors
27.01.2012 Antitrust: Commission closes procedural case against Servier
15.12.2011 Mergers: Commission approves acquisition of Belgian health company Omega Pharma by private equity fund manager Waterland and Belgian Alychlo
21.10.2011 Antitrust: Commission opens proceedings against Johnson & Johnson and Novartis
07.07.2011 Mergers: Commission approves acquisition of Janssen Animal Health by pharmaceutical group Eli Lilly
10.06.2011 Mergers: Commission approves acquisition of Ferrosan's Consumer Health Care Business by Pfizer
19.05.2011 Mergers: Commission clears proposed joint venture between Dutch pharma company DSM and Sinochem
28.04.2011 Antitrust: Commission opens investigation against pharmaceutical companies Cephalon and Teva
21.02.2011 Commission clears acquisition of joint control over Actamax by DSM and DuPont
17.01.2011 Antitrust: Commission launches second monitoring exercise of patent settlements in pharma sector
12.01.2011 Mergers: Commission clears proposed acquisition of Genzyme by Sanofi-Aventis






  
  
Related links
Antitrust: latest case documents (all sectors)
Mergers: latest case documents (all sectors)
State Aid: latest case documents (all sectors)